The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Abstract
Objective. —To determine the relationship of brain infarction to the clinical expression of Alzheimer disease (AD). Design. —Cognitive function and the prevalence of dementia were determined for participants in the Nun Study who later died. At autopsy, lacunar and larger brain infarcts were identified, and senile plaques and neurofibrillary tangles in the neocortex were quantitated. Participants with abundant senile plaques and some neurofibrillary tangles in the neocortex were classified as having met the neuropathologic criteria for AD. Setting. —Convents in the Midwestern, Eastern, and Southern United States. Participants. —A total of 102 college-educated women aged 76 to 100 years. Main Outcome Measures. —Cognitive function assessed by standard tests and dementia and AD assessed by clinical and neuropathologic criteria. Results. —Among 61 participants who met the neuropathologic criteria for AD, those with brain infarcts had poorer cognitive function and a higher prevalence of dementia than those without infarcts. Participants with lacunar infarcts in the basal ganglia, thalamus, or deep white matter had an especially high prevalence of dementia, compared with those without infarcts (the odds ratio [OR] for dementia was 20.7,95% confidence interval [95% CI], 1.5-288.0). Fewer neuropathologic lesions of AD appeared to result in dementia in those with lacunar infarcts in the basal ganglia, thalamus, or deep white matter than in those without infarcts. In contrast, among 41 participants who did not meet the neuropathologic criteria for AD, brain infarcts were only weakly associated with poor cognitive function and dementia. Among all 102 participants, atherosclerosis of the circle of Willis was strongly associated with lacunar and large brain infarcts. Conclusion. —These findings suggest that cerebrovascular disease may play an important role in determining the presence and severity of the clinical symptoms of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Population-autopsy series verified the high frequency and pathogenetic importance of combined Alzheimer disease and vascular disease in the expression of dementia as mentioned previously.”
In the citing paper
“Furthermore, vascular lesions can lower the threshold for the clinical manifestation of Alzheimer disease.”
In the citing paper
“Several studies have found that in patients with Alzheimer disease and cerebrovascular disease, less Alzheimer disease pathology is needed to express the dementia syndrome.”
In the citing paper
“typically are accompanied by Alzheimer disease and other pathologies.”
In the citing paper
“Infarcts frequently coexist with Alzheimer disease pathology in the brains of older people.”
In the citing paper
“One study showed that only people with Alzheimer disease pathology with subcortical infarcts had dementia, raising the possibility of an interaction (a multiplicative effect) between the 2 pathologies.”
In the citing paper
“It is now accepted that many of the traditional risk factors for stroke are also risk markers for Alzheimer disease and VCI.16,31,340,484–491”
In the citing paper
“Lacunes are frequently seen on imaging in elderly patients with no symptoms”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [25]
In the citing paper
“are associated with an increased risk of stroke, gait impairment, and dementia.”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [25]
In the citing paper
“Cerebrovascular effects of APOE4 are associated with AD, stroke, and brain hemorrhage (314, 506, 549, 614, 693).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [549]
In the citing paper
“Classical anatomic locations for strategic infarcts include the thalamus, angular gyrus, and basal ganglia, including the caudate nucleus and globus pallidus. 52-57”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“A single small infarct may cause severe cognitive deficits when located in a strategic brain region.”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“However, vascular brain lesions lower the threshold of AD pathology required to induce dementia. 56,100-102”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“Earlier studies have suggested a multiplicative effect between vascular and AD-type pathology on cognitive decline, 56 whereas recent studies indicate that the effects are additive. 49,100,105”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“many older individuals with dementia suffer from a combination of vascular and Alzheimer-type pathology with an additive effect on cognition,19”
From Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement (2014) · cites this paper as [19]
In the citing paper
“On the other hand, in older individuals with moderate AD pathology subcortical vascular lesions are a major determinant of the expression of the dementia (Esiri et al., 1999; Schneider et al., 2007b; Snowdon et al., 1997).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Snowdon et al., 1997
In the citing paper
“it seems reasonable to postulate that insulin resistance and T2D could increase AD risk through cerebrovascular disease, a factor increasingly accepted to be important in AD manifestation [5, 19-21].”
From Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial (2016) · cites this paper as [5]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 701–800 of 1,644
Clinical significance of subcortical vascular disease in patients with mild cognitive impairment
de Mendonça, A., Ribeiro, F., Guerreiro, M., Palma, T., & García, C. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00892.x · Cited by 45
Cognitive health begins at conception: addressing dementia as a lifelong and preventable condition
Barnett, J., Hachinski, V., & Blackwell, A. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-246 · Cited by 46
Li, W., Antuono, P., Xie, C., Chen, G., Jones, J. L., Ward, B. D., Singh, S. P., Franczak, M. B., Goveas, J. S., & Li, S. (2014) · Cortex · doi:10.1016/j.cortex.2014.04.006 · Cited by 46
Ramos‐Miguel, A., Hercher, C., Beasley, C. L., Barr, A. M., Bayer, T. A., Falkai, P., Leurgans, S. E., Schneider, J. A., Bennett, D. A., & Honer, W. G. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0061-4 · Cited by 45
Diabetes and neurodegeneration in the brain
Toth, C. C. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00035-7 · Cited by 47
Glycemia, Diabetes Status, and Cognition in Hispanic Adults Aged 55–64 Years
Luchsinger, J. A., Cabral, R., Eimicke, J. P., Manly, J. J., & Teresi, J. A. (2015) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000208 · Cited by 46
Amyloid-β (1-40) and Mortality in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome
Stamatelopoulos, K. S., Mueller‐Hennessen, M., Georgiopoulos, G. A., Sachse, M., Boeddinghaus, J., Sopova, K., Gatsiou, A., Amrhein, C., Biener, M., Vafaie, M., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m17-1540 · Cited by 47
Spence, J. D. (2019) · Brain Sciences · doi:10.3390/brainsci9020021 · Cited by 47
Cerebral white matter disease is associated with Alzheimer pathology in a prospective cohort
Moghekar, A., Kraut, M. A., Elkins, W., Troncoso, J. C., Zonderman, A. B., Resnick, S. M., & O’Brien, R. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.04.006 · Cited by 47
Clinical Significance of Silent Cerebral Infarctions in Patients With Alzheimer Disease
Song, I., Kim, J., Kim, Y.-I., Eah, K., & Lee, K.-S. (2007) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e31805d859e · Cited by 43
Joint effect of stroke and APOE 4 on dementia risk
Jin, Y.-P., Østbye, T., Feightner, J., Legge, S. D., & Hachinski, V. (2007) · Neurology · doi:10.1212/01.wnl.0000284609.77385.03 · Cited by 46
The influence of coincidental vascular pathology on symptomatology and course of Alzheimer’s disease
Pasquier, F., Leys, D., & Scheltens, P. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-7508-8_11 · Cited by 46
Naidu, A., Xu, Q., Catalano, R., & Cordell, B. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03480-7 · Cited by 46
Folate, Homocysteine, and Neurological Function
Morris, M. S. (2002) · Nutrition in Clinical Care · doi:10.1046/j.1523-5408.2002.t01-1-00006.x · Cited by 48
Diagnosing vascular cognitive impairment and dementia: concepts and controversies
Erkinjuntti, T., & Gauthier, S. G. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511575976.002 · Cited by 44
Traini, E., Carotenuto, A., Fasanaro, A. M., & Amenta, F. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190623 · Cited by 46
Renin–angiotensin–aldosterone system has a pivotal role in cognitive impairment
Yagi, S., Akaike, M., Ise, T., Ueda, Y., Iwase, T., & Sata, M. (2013) · Hypertension Research · doi:10.1038/hr.2013.51 · Cited by 44
Small vessel disease burden in cerebral amyloid angiopathy without symptomatic hemorrhage
Boulouis, G., Charidimou, A., Jessel, M. J., Xiong, L., Roongpiboonsopit, D., Fotiadis, P., Pasi, M., Ayres, A. M., Merrill, M. E., Schwab, K. M., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000003655 · Cited by 45
Deconstructing and targeting the genomic architecture of human neurodegeneration
Jager, P. L. D., Yang, H., & Bennett, D. A. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0240-z · Cited by 46
Rasmussen, I. J., Tybjærg‐Hansen, A., Rasmussen, K. L., Nordestgaard, B. G., & Frikke‐Schmidt, R. (2019) · European Journal of Epidemiology · doi:10.1007/s10654-019-00498-2 · Cited by 46
Ułamek-Kozioł, M., Czuczwar, S. J., Januszewski, S., & Pluta, R. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030892 · Cited by 46
Subcortical Vascular Dementia as a Specific Target for Clinical Trials
Inzitari, D., Erkinjuntti, T., Wallin, A., del Ser, T., Romanelli, M., & Pantoni, L. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06407.x · Cited by 45
Vascular cognitive impairment: Today and tomorrow
Chui, H. C. (2006) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2006.03.003 · Cited by 44
Associations between white matter lesions, cerebrovascular risk factors, and low CSF Aβ42
Stenset, V., Johnsen, L., Kocot, D., Negaard, A., Skinningsrud, A., Gulbrandsen, P., Wallin, A., & Fladby, T. (2006) · Neurology · doi:10.1212/01.wnl.0000234030.77831.5a · Cited by 44
Cordone, S., Scarpelli, S., Alfonsi, V., Gennaro, L. D., & Gorgoni, M. (2021) · Pharmaceuticals · doi:10.3390/ph14040383 · Cited by 50
ASPIRIN USE, DEPRESSION, AND COGNITIVE IMPAIRMENT IN LATER LIFE: THE HEALTH IN MEN STUDY
Almeida, O. P., Alfonso, H. S., Jamrozik, K. D., Hankey, G. J., & Flicker, L. A. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02827.x · Cited by 44
Suribhatla, S., Baillon, S. F., Dennis, M., Marudkar, M., Muhammad, S., Munro, D., Spreadbury, C., & Lindesay, J. E. B. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1196 · Cited by 44
Postmortem Indices Linking Risk Factors to Cognition
Bennett, D. A. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200607001-00009 · Cited by 46
Massoud, F., Devi, G., Moroney, J., Stern, Y., Lawton, A., Bell, K., Marder, K., & Mayeux, R. (2000) · Journal of The American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb02591.x · Cited by 45
Interactions between vascular burden and amyloid-β pathology on trajectories of tau accumulation
Coomans, E. M., van Westen, D., Binette, A. P., Strandberg, O. T., Spotorno, N., Serrano, G. E., Beach, T. G., Palmqvist, S., Stomrud, E., Ossenkoppele, R., et al. (2023) · Brain · doi:10.1093/brain/awad317 · Cited by 47
Detrimental Roles of Hypoxia-Inducible Factor-1α in Severe Hypoxic Brain Diseases
Choi, Y. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084465 · Cited by 45
Amyloid and Tau accumulate in the brains of aged hydrocephalic rats
Silverberg, G. D., Miller, M. C., Machan, J. T., Johanson, C. E., Caralopoulos, I. N., Pascale, C. L., Heile, A., & Klinge, P. M. (2010) · Brain Research · doi:10.1016/j.brainres.2009.12.065 · Cited by 43
Small Vascular and Alzheimer Disease-Related Pathologic Determinants of Dementia in the Oldest-Old
Sinka, L., Kövari, E., Gold, G., Hof, P. R., Herrmann, F. R., Bouras, C., & Giannakopoulos, P. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181ffc3b9 · Cited by 44
Alzheimer’s Disease and the Blood–Brain Barrier: Past, Present and Future
Bowman, G. L., & Quinn, J. F. (2008) · Aging Health · doi:10.2217/1745509x.4.1.47 · Cited by 43
Cognitive impairment and the role of the ApoE ε4‐allele after stroke—a 13 months follow‐up study
Wagle, J., Farner, L., Flekkøy, K., Wyller, T. B., Sandvik, L., Eiklid, K. L., Fure, B., Stensrød, B., & Engedal, K. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2425 · Cited by 43
Depression as a risk factor for cognitive impairment in later life: the Health In Men cohort study
Almeida, O. P., Hankey, G. J., Yeap, B. B., Golledge, J., & Flicker, L. A. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4347 · Cited by 43
Oikonomidi, A., Lewczuk, P., Kornhuber, J., Smulders, Y., Linnebank, M., Semmler, A., & Popp, J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13766 · Cited by 38
Liu, P., Reichl, J. H., Rao, E. R., McNellis, B. M., Huang, E. S., Hemmy, L. S., Forster, C. L., Kuskowski, M. A., Borchelt, D., Vassar, R. J., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-161027 · Cited by 41
Akinyemi, R., Allan, L. M., Oakley, A. E., & Kalaria, R. N. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00717 · Cited by 43
The Tumor Necrosis Factor Alpha −308G>A Polymorphism Is Associated with Dementia in the Oldest Old
Brüünsgaard, H., Benfield, T., Andersen‐Ranberg, K., Hjelmborg, J., Pedersen, A. N., Schroll, M., Pedersen, B. K., & Jeune, B. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52369.x · Cited by 43
Increased locomotor activity in mice lacking the low-density lipoprotein receptor
Elder, G. A., Ragnauth, A. K., Dorr, N. P., Franciosi, S., Schmeidler, J., Haroutunian, V. H., & Buxbaum, J. D. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.03.036 · Cited by 45
White Matter Hyperintensities and Cognitive Dysfunction in Alzheimer Disease
Heo, J., Lee, S., Chu, K., Park, H.-J., Shim, J.-Y., & Kim, M. (2009) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988709335800 · Cited by 43
Frontal MRI Findings Associated With Impairment on the Executive Interview (EXIT25)
Royall, D. R., Rauch, R. A., Román, G. C., Cordes, J. A., & Polk, M. J. (2001) · Experimental Aging Research · doi:10.1080/03610730109342350 · Cited by 42
Alzheimer disease versus mixed dementias: An EEG perspective
Schreiter-Gasser, U., Rousson, V., Hentschel, F., Sattel, H. C., & Gasser, T. (2008) · Clinical Neurophysiology · doi:10.1016/j.clinph.2008.07.216 · Cited by 42
Esiri, M. M., Joachim, C., Sloan, C., Christie, S., Agacinski, G., Bridges, L. R., Wilcock, G. K., & Smith, A. D. (2014) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31829b72f1 · Cited by 42
Vascular factors and prevention of dementia
Stephan, B. C. M., & Brayne, C. (2008) · International Review of Psychiatry · doi:10.1080/09540260802094456 · Cited by 42
Increased risk of dementia in patients with Schizophrenia: A population-based cohort study in Taiwan
Lin, C.-E., Chung, C., Chen, L., & Chi, M. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2018.05.005 · Cited by 44
Cognitive aging and Alzheimer’s disease
Vandenberghe, R. R., & Tournoy, J. (2005) · Postgraduate Medical Journal · doi:10.1136/pgmj.2004.028290 · Cited by 45
Periventricular White Matter Hyperintensities on MRI: Correlation With Neuropathologic Findings
Smith, C. D., Snowdon, D. A., & Markesbery, W. R. (2000) · Journal of Neuroimaging · doi:10.1111/jon200010113 · Cited by 42
Self-citationMcCarty, M. F. (2000) · Medical Hypotheses · doi:10.1054/mehy.2000.1075 · Cited by 43
Genetics of Vascular Cognitive Impairment
Leblanc, G. G., Meschia, J. F., Stuss, D. T., & Hachinski, V. (2005) · Stroke · doi:10.1161/01.str.0000195177.61184.49 · Cited by 42
Histone-acetylation: a link between Alzheimer's disease and post-traumatic stress disorder?
Bahari‐Javan, S., Sananbenesi, F., & Fischer, A. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00160 · Cited by 40
Mixed dementia: Neglected clinical entity or nosographic artifice?
Fierini, F. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.116662 · Cited by 46
NINDS AIREN neuroimaging criteria do not distinguish stroke patients with and without dementia
Ballard, C. G., Burton, E. J., Barber, R., Stephens, S., Kenny, R. A., Kalaria, R. N., & O'Brien, J. T. (2004) · Neurology · doi:10.1212/01.wnl.0000138435.19761.93 · Cited by 41
Neuropathology Lessons in Vascular Dementia
Chui, H. C. (2005) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000155065.31561.0a · Cited by 41
Bürger, S., Noack, M., Kirazov, L., Kirazov, E. P., Naydenov, C. L., Kouznetsova, E., Yafai, Y., & Schliebs, R. (2009) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2009.06.011 · Cited by 42
Pharmacotherapeutic approaches to the prevention of Alzheimer's disease
Standridge, J. B. (2004) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/s1543-5946(04)90017-7 · Cited by 41
David Bartrés-faz, A., Junqué, C., Clemente, I. C., López‐Alomar, A., Valveny, N., López-Guillén, A., López, T., Cubells, M. J., & Moral, P. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01349-5 · Cited by 41
Auchus, A. P., Chen, C. P. L. H., Sodagar, S. N., Thong, M., & Sng, E. C. S. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00272-1 · Cited by 40
Prevention of Alzheimer's disease
Szekely, C. A., Breitner, J. C. S., & Zandi, P. P. (2007) · International Review of Psychiatry · doi:10.1080/09540260701797944 · Cited by 41
Fukui, T., Owan, Y., Yamazaki, T., & Kinno, R. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000351423 · Cited by 40
Population‐based analysis of pathological correlates of dementia in the oldest old
Tanskanen, M., Mäkelä, M., Notkola, I., Myllykangas, L., Rastas, S., Oinas, M., Lindsberg, P. J., Polvikoski, T. M., Tienari, P. J., & Paetau, A. E. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.389 · Cited by 41
White matter alterations in Alzheimer’s disease without concomitant pathologies
Ferrer, I., & Andrés‐Benito, P. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12618 · Cited by 38
Brain amyloid β, cerebral small vessel disease, and cognition
Saridin, F. N., Hilal, S., Villaraza, S., Reilhac, A., Gyanwali, B., Tanaka, T., Stephenson, M., Ng, S., Vrooman, H., van der Flier, W. M., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000011029 · Cited by 35
Identification of digital voice biomarkers for cognitive health
Lin, H., Karjadi, C., Ang, T. F. A., Joshi, P. S., McManus, C., Alhanai, T., Glass, J. R., & Au, R. (2020) · Exploration of Medicine · doi:10.37349/emed.2020.00028 · Cited by 42
Is Cerebral Amyloid-β Deposition Related to Post-stroke Cognitive Impairment?
Ouyang, F., Jiang, Z., Chen, X., Chen, Y., Wei, J., Xing, S., Zhang, J., Fan, Y., & Zeng, J. (2021) · Translational Stroke Research · doi:10.1007/s12975-021-00921-5 · Cited by 41
Vascular risk burden is a key player in the early progression of Alzheimer’s disease
Ferrari‐Souza, J. P., Brum, W. S., Hauschild, L. A., Ros, L. U. D., Ferreira, P. C. L., Bellaver, B., Leffa, D. T., Bieger, A., Tissot, C., Lussier, F. Z., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.12.008 · Cited by 40
Sheng, B., Law, C. B., & Yeung, K. M. (2008) · International Psychogeriatrics · doi:10.1017/s104161020800817x · Cited by 40
Linguistic Ability in Early Life and Longevity: Findings from the Nun Study
Snowdon, D. A., Greiner, L. H., Kemper, S., Nanayakkara, N. D., & Mortimer, J. A. (1999) · Springer eBooks · doi:10.1007/978-3-642-60100-2_9 · Cited by 40
Self-citationGAINOTTI, G., FERRACCIOLI, M., VITA, M. G., & MARRA, C. (2008) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617708080831 · Cited by 39
Visit‐to‐visit blood pressure variability and dementia
Nagai, M., Hoshide, S., Dote, K., & Kario, K. (2015) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12660 · Cited by 39
Vascular contributions to cognitive impairment and dementia (VCID)
Murphy, M. P., Corriveau, R. A., & Wilcock, D. M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.02.010 · Cited by 39
A Multimodal Structural and Functional Neuroimaging Study of Amnestic Mild Cognitive Impairment
Bharath, S., Joshi, H., John, J. P., Balachandar, R., Sadanand, S., Saini, J., Kumar, K. J., & Varghese, M. (2016) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.05.001 · Cited by 38
Zsoldos, E., Filippini, N., Mahmood, A., Mackay, C. E., Singh‐Manoux, A., Mika Kivimaki, B., Jenkinson, M., & Ebmeier, K. P. (2018) · Scientific Reports · doi:10.1038/s41598-018-24398-9 · Cited by 37
Hereditary and Sporadic Forms of Aβ-Cerebrovascular Amyloidosis and Relevant Transgenic Mouse Models
Kumar‐Singh, S. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10041872 · Cited by 40
Enhanced soluble CD40 ligand and Alzheimer's disease: Evidence of a possible pathogenetic role
Desideri, G., Cipollone, F., Necozione, S., Marini, C., Lechiara, M. C., Taglieri, G., Zuliani, G., Fellin, R., Mezzetti, A., di Orio, F., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.10.019 · Cited by 38
Quality Indicators for Dementia in Vulnerable Community-Dwelling and Hospitalized Elders
Chow, T. W., & MacLean, C. H. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-8_part_2-200110161-00005 · Cited by 36
Atherosclerosis and Neurodegeneration
Iadecola, C. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000102660.99744.85 · Cited by 39
Corneal Nerve and Brain Imaging in Mild Cognitive Impairment and Dementia
Al-Janahi, E., Ponirakis, G., Hamad, H. K. A., Vattoth, S., Elsotouhy, A., Petropoulos, I. N., Khan, A., Gad, H., Chandran, M., Sankaranarayanan, A., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200678 · Cited by 41
Age-related influence of the HDL receptor SR-BI on synaptic plasticity and cognition
Chang, E. H., Rigotti, A., & Huerta, P. T. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.006 · Cited by 35
Vascular Cognitive Impairment and Dementia
Sachdev, P. S., Bentvelzen, A. C., Gustafson, D., Hansra, G. K., Hosoki, S., Jiang, J., Lennon, M. J., Moro, M. Á., Saks, D., Samaras, K., et al. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.11.008 · Cited by 43
Neuroprotection in vascular dementia: A future path
Skoog, I. G., Korczyn, A. D., & Guekht, A. B. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.02.013 · Cited by 38
Skogen, J. C., Bergh, S., Stewart, R. J., Knudsen, A. K., & Bjerkeset, O. A. (2015) · BMC Geriatrics · doi:10.1186/s12877-015-0020-5 · Cited by 40
Molecular Links and Biomarkers of Stroke, Vascular Dementia, and Alzheimer's Disease
Vijayan, M., Kumar, S., Bhatti, J. S., & Reddy, P. H. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.014 · Cited by 37
Vascular cognitive impairment: Advances and trends
Barbay, M., Taillia, H., Nédélec-Ciceri, C., Arnoux, A., Puy, L., Wiener, E., Canaple, S., Lamy, C., Godefroy, O., & Roussel, M. (2017) · Revue Neurologique · doi:10.1016/j.neurol.2017.06.009 · Cited by 39
Cognitive Function and Ophthalmological Diseases: The Beijing Eye Study
Jonas, J. B., Wei, W. B., Zhu, L., Xu, L., & Wang, Y. X. (2018) · Scientific Reports · doi:10.1038/s41598-018-23314-5 · Cited by 38
Wijesinghe, P., Steinbusch, H. W. M., Shankar, S. K., Yasha, T. C., & de Silva, K. R. D. (2020) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2020.101772 · Cited by 40
Pluta, R. M., Furmaga-Jabłońska, W., Januszewski, S., & Czuczwar, S. J. (2022) · Nutrients · doi:10.3390/nu14020248 · Cited by 39
Influence of genetic and cardiometabolic risk factors in Alzheimer’s disease
Pasqualetti, G., Thayanandan, T., & Edison, P. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101723 · Cited by 39
Büerger, K., Ernst, A. S., Ewers, M., Uspenskaya, O., Omerovic, M., Morgenthaler, N. G., Knauer, K., Bergmann, A., & Hampel, H. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.032 · Cited by 38
Brookes, R. L., Hannesdóttir, K., Lawrence, R., Morris, R. G., & Markus, H. S. (2012) · Age and Ageing · doi:10.1093/ageing/afr172 · Cited by 38
Small, G. W., Erkinjuntti, T., Kurz, A., & Lilienfeld, S. (2003) · CNS Drugs · doi:10.2165/00023210-200317120-00004 · Cited by 37
Hasegawa, Y., Yamaguchi, T., Omae, T., Woodward, M., Chalmers, J. P., & PROGRESS CT Substudy Investigators (2004) · Hypertension Research · doi:10.1291/hypres.27.147 · Cited by 38
Alzheimer's Disease, Genes, and Environment: The Value of International Studies
Hendrie, H., Hall, K., Ogunniyi, A., & Gao, S.-J. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404900203 · Cited by 16
Rockwood, K. J. (1997) · International Psychogeriatrics · doi:10.1017/s1041610297004407 · Cited by 37
Jellinger, K. A. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.520 · Cited by 37
Li, Z., McConnell, H., Stackhouse, T. L., Pike, M. M., Zhang, W. H., & Mishra, A. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.762843 · Cited by 39
A novel therapeutic effect of statins on nephrogenic diabetes insipidus
Bonfrate, L., Procino, G., Wang, D. Q. ‐., Svelto, M., & Portincasa, P. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12422 · Cited by 36
Dementia and serious coexisting medical conditions: a double whammy
Maslow, K. (2004) · Nursing Clinics of North America · doi:10.1016/j.cnur.2004.02.011 · Cited by 38
Rocque, B. G., Jackson, D. C., Varghese, T., Hermann, B. P., McCormick, M. M., Kliewer, M. A., Mitchell, C., & Dempsey, R. J. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.05.020 · Cited by 37
Metadata
- Authors
- Snowdon, D. A.
- Corresponding author
- Snowdon, David A.
- ORCID
- Snowdon, David A.
- Venue
- JAMA: The Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1997-03-12
- Volume
- 277
- Issue
- 10
- Pages
- 813
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4296588155
- Cited by
- 1,590
- References
- 0
- Citations by year
- 2026: 23 · 2025: 31 · 2024: 30 · 2023: 39 · 2022: 43 · 2021: 42 · 2020: 51 · 2019: 57 · 2018: 52 · 2017: 60 · 2016: 74 · 2015: 63 · 2014: 71 · 2013: 61 · 2012: 74
- FWCI
- 34.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- Funders
- National Institute on Aging (R01AG009862, P50AG005144, KO4AG00553)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, cerebral infarction, lacunar infarction, dementia, cognitive function, amyloid plaques, neurofibrillary tangles, cerebrovascular disease, atherosclerosis, circle of Willis, thalamic infarction, basal ganglia infarcts, older women, neuropathology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
